Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

Autor: Julia Stockmann, Inge M. W. Verberk, Nina Timmesfeld, Robin Denz, Brian Budde, Julia Lange-Leifhelm, Philip Scheltens, Wiesje M. van der Flier, Andreas Nabers, Charlotte E. Teunissen, Klaus Gerwert

Publikováno v: Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)

Abstract Background We evaluated Aβ misfolding in combination with Aβ42/40 ratio as a prognostic tool for future clinical progression to mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) in individuals with subjective co

Externí odkaz: https://doaj.org/article/01b9f2a3ace648689f1dd585d885dfe9

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

Autor: Philip Scheltens, Nina Timmesfeld, Inge M.W. Verberk, Brian Budde, Julia Stockmann, Charlotte E. Teunissen, Andreas Nabers, Julia Lange-Leifhelm, Wiesje M. van der Flier, Klaus Gerwert, Robin Denz

Publikováno v: Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Stockmann, J, Verberk, I M W, Timmesfeld, N, Denz, R, Budde, B, Lange-Leifhelm, J, Scheltens, P, van der Flier, W M, Nabers, A, Teunissen, C E & Gerwert, K 2020, ' Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline ', Alzheimer's Research and Therapy, vol. 12, no. 1, 169 . https://doi.org/10.1186/s13195-020-00738-8
Alzheimer's Research & Therapy
Alzheimer's Research and Therapy, 12(1):169. BioMed Central

Background We evaluated Aβ misfolding in combination with Aβ42/40 ratio as a prognostic tool for future clinical progression to mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) in individuals with subjective cognitive d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdaad83a0f687f039609af27af760f1e
https://doaj.org/article/01b9f2a3ace648689f1dd585d885dfe9